Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
16.81
-0.60 (-3.45%)
At close: Nov 14, 2025, 4:00 PM EST
16.93
+0.12 (0.71%)
After-hours: Nov 14, 2025, 4:04 PM EST
Lyell Immunopharma Market Cap
Lyell Immunopharma has a market cap or net worth of $325.25 million as of November 14, 2025. Its market cap has increased by 48.02% in one year.
Market Cap
325.25M
Enterprise Value
49.91M
1-Year Change
48.02%
Ranking
Category
Stock Price
$16.81
Market Cap Chart
Since the IPO on June 17, 2021, Lyell Immunopharma's market cap has decreased from $4.13B to $325.25M, a decrease of -92.12%. That is a compound annual growth rate of -43.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 325.25M | 73.94% |
| Dec 31, 2024 | 186.98M | -61.73% |
| Dec 29, 2023 | 488.63M | -43.52% |
| Dec 30, 2022 | 865.16M | -53.52% |
| Dec 31, 2021 | 1.86B | -54.91% |
| Jun 17, 2021 | 4.13B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 911.30B |
| Johnson & Johnson | 468.34B |
| AbbVie | 412.21B |
| UnitedHealth Group | 307.13B |
| AstraZeneca | 275.24B |
| Novartis AG | 251.93B |
| Merck & Co. | 226.98B |
| Abbott Laboratories | 224.00B |